Skip to main content
Top
Published in: Abdominal Radiology 6/2015

01-08-2015

Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus

Authors: Yulia Lakhman, Derya Yakar, Debra A. Goldman, Seth S. Katz, Hebert A. Vargas, Maura Miccò, Junting Zheng, Chaya S. Moskowitz, Robert A. Soslow, Hedvig Hricak, Nadeem R. Abu-Rustum, Evis Sala

Published in: Abdominal Radiology | Issue 6/2015

Login to get access

Abstract

Purpose

To develop a preoperative CT-based nomogram for predicting overall survival (OS) in patients with non-endometrioid carcinomas of the uterine corpus.

Methods

Waiving informed consent, the institutional review board approved this HIPAA-compliant, retrospective study of 193 women with histopathologically proven uterine papillary serous carcinomas (UPSC), uterine clear cell carcinomas (UCCC), and uterine carcinosarcomas (UCS) who underwent primary surgical resection between May 1998 and December 2011, and had a preoperative CT ≤ 6 weeks before surgery. All CT scans were reviewed for local or/and regional tumor extent, presence of pelvic or/and para-aortic adenopathy, and presence of distant metastases. Univariate survival analysis was performed using log-rank test and Cox regression. Variables shown significant by the univariate analysis were evaluated with the multivariable Cox regression analysis and the results were used to create a nomogram for predicting OS. The predictive accuracy of the nomogram was assessed with the concordance probability index (c-index) and a 3-year calibration plot.

Results

Mean patient age was 67.2 years (range 49.0–85.9); histologies included UPSC (n = 116), UCCC (n = 27), and UCS (n = 50). Median follow-up was 38.1 months (0.9–168.5 months). At multivariate analysis, patient age, ascites, and omental implants on CT were significant adverse predictors of OS and were used to build the nomogram. Concordance index for the nomogram was 0.640 ± 0.028.

Conclusion

We developed a nomogram with a good concordance probability at predicting OS based on readily available pretreatment clinical and imaging characteristics. This preoperative nomogram has the potential to improve initial treatment planning and patient counseling.
Literature
1.
go back to reference Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364–1370.PubMedCrossRef Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364–1370.PubMedCrossRef
2.
go back to reference Kattan MW (2003) Nomograms are superior to staging and risk grouping systems for identifying high risk patients: preoperative application in prostate cancer. Curr Opin Urol 13:111–116.PubMedCrossRef Kattan MW (2003) Nomograms are superior to staging and risk grouping systems for identifying high risk patients: preoperative application in prostate cancer. Curr Opin Urol 13:111–116.PubMedCrossRef
3.
go back to reference Mariani L, Miceli R, Kattan MW, et al. (2005) Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 103:402–408.PubMedCrossRef Mariani L, Miceli R, Kattan MW, et al. (2005) Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 103:402–408.PubMedCrossRef
4.
go back to reference Wang L, Hricak H, Kattan MW, et al. (2006) Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238:597–603.PubMedCrossRef Wang L, Hricak H, Kattan MW, et al. (2006) Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238:597–603.PubMedCrossRef
5.
go back to reference Wong SL, Kattan MW, McMasters KM, Coit DG (2005) A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol 12:282–288.PubMedCrossRef Wong SL, Kattan MW, McMasters KM, Coit DG (2005) A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol 12:282–288.PubMedCrossRef
6.
go back to reference Ohori M, Kattan MW, Koh H, et al. (2004) Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 171:1844–1849.PubMedCrossRef Ohori M, Kattan MW, Koh H, et al. (2004) Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 171:1844–1849.PubMedCrossRef
7.
go back to reference American Cancer Society. (2011) Global cancer facts and figures, 2nd edn. Atlanta: American Cancer Society. American Cancer Society. (2011) Global cancer facts and figures, 2nd edn. Atlanta: American Cancer Society.
8.
go back to reference Doll A, Abal M, Rigau M, et al. (2008) Novel molecular profiles of endometrial cancer—new light through old windows. J Steroid Biochem Mol Biol 108:221–229.PubMedCrossRef Doll A, Abal M, Rigau M, et al. (2008) Novel molecular profiles of endometrial cancer—new light through old windows. J Steroid Biochem Mol Biol 108:221–229.PubMedCrossRef
9.
go back to reference Tejerizo-Garcia A, Jimenez-Lopez JS, Munoz-Gonzalez JL, et al. (2013) Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients. OncoTargets Ther 9:1305–1313. Tejerizo-Garcia A, Jimenez-Lopez JS, Munoz-Gonzalez JL, et al. (2013) Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients. OncoTargets Ther 9:1305–1313.
10.
go back to reference Hendrickson M, Ross J, Eifel PJ, et al. (1982) Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus—pathology review and analysis of prognostic factors. Gynecol Oncol 13:373–392.PubMedCrossRef Hendrickson M, Ross J, Eifel PJ, et al. (1982) Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus—pathology review and analysis of prognostic factors. Gynecol Oncol 13:373–392.PubMedCrossRef
12.
go back to reference Abu-Rustum NR, Zhou Q, Gomez JD, et al. (2010) A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol 116:399–403.PubMedCrossRef Abu-Rustum NR, Zhou Q, Gomez JD, et al. (2010) A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol 116:399–403.PubMedCrossRef
13.
go back to reference Polterauer S, Zhou Q, Grimm C, et al. (2012) External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer. Gynecol Oncol 125:526–530.PubMedCrossRef Polterauer S, Zhou Q, Grimm C, et al. (2012) External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer. Gynecol Oncol 125:526–530.PubMedCrossRef
14.
go back to reference Koskas M, Bendifallah S, Luton D, Darai E, Rouzier R (2011) Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer. Gynecol Oncol 123:214–220.PubMedCrossRef Koskas M, Bendifallah S, Luton D, Darai E, Rouzier R (2011) Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer. Gynecol Oncol 123:214–220.PubMedCrossRef
15.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174.PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174.PubMedCrossRef
16.
go back to reference Gonen M, Heller G (2005) Concordance probability and discriminatory power in proportional hazards regression. Biometrika 92:965–970.CrossRef Gonen M, Heller G (2005) Concordance probability and discriminatory power in proportional hazards regression. Biometrika 92:965–970.CrossRef
17.
go back to reference Efron B, Tibshirani R (1993) An introduction to the bootstrap. New York: Chapman and Hall.CrossRef Efron B, Tibshirani R (1993) An introduction to the bootstrap. New York: Chapman and Hall.CrossRef
18.
go back to reference Vance S, Yechieli R, Cogan C, et al. (2012) The prognostic significance of age in surgically staged patients with type II endometrial carcinoma. Gynecol Oncol 126:16–19.PubMedCrossRef Vance S, Yechieli R, Cogan C, et al. (2012) The prognostic significance of age in surgically staged patients with type II endometrial carcinoma. Gynecol Oncol 126:16–19.PubMedCrossRef
19.
go back to reference Fader AN, Starks D, Gehrig PA, et al. (2009) An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). Gynecol Oncol 115:244–248.PubMedCrossRef Fader AN, Starks D, Gehrig PA, et al. (2009) An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). Gynecol Oncol 115:244–248.PubMedCrossRef
20.
go back to reference Sala E, Wakely S, Senior E, Lomas D (2007) MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188:1577–1587.PubMedCrossRef Sala E, Wakely S, Senior E, Lomas D (2007) MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188:1577–1587.PubMedCrossRef
Metadata
Title
Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus
Authors
Yulia Lakhman
Derya Yakar
Debra A. Goldman
Seth S. Katz
Hebert A. Vargas
Maura Miccò
Junting Zheng
Chaya S. Moskowitz
Robert A. Soslow
Hedvig Hricak
Nadeem R. Abu-Rustum
Evis Sala
Publication date
01-08-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0337-0

Other articles of this Issue 6/2015

Abdominal Radiology 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.